Alina thrives on finding the unique spot where complex science, fresh ideas and regulatory requirements can all work for a brand. Franchise and product communications across the life cycle, from clinical trials through approval, launch and maturation, have been her career focus. She has extensive experience partnering with leading pharma and biotech companies to identify, tackle and master communications challenges from first-of-its-kind data to late-market entry and beyond.
B2 is part of INC Research/inVentiv Health, an industry-changing new company, purpose-built to help the industry achieve a singular goal: Biopharmaceutical Acceleration. The coming together of two dedicated businesses allows us to address new market realities through clinical and commercial sharing expertise, data and insights to meet the needs of global biopharmaceutical companies of all sizes to speed the delivery of therapies to patients worldwide.